Read + Share
Ishikawa K, Nascimento MC, Asano M, Hirata H, et al. One year safety and immunogenicity of AZD1222 (ChAdOx1 nCoV-19): Final analysis
of a randomized, placebo-controlled phase 1/2 trial in Japan. Vaccine 2023;41:4199-4205.
PMID: 37271703
|
 |
|
